[Federal Register Volume 89, Number 53 (Monday, March 18, 2024)]
[Notices]
[Page 19295]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05676]



[[Page 19295]]

-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-12-2024]


Foreign-Trade Zone (FTZ) 49, Notification of Proposed Production 
Activity; Merck Sharp & Dohme LLC; (Pharmaceutical Products for 
Research and Development); Rahway, New Jersey

    Merck Sharp & Dohme LLC submitted a notification of proposed 
production activity to the FTZ Board (the Board) for its facility in 
Rahway, New Jersey, within FTZ 49. The notification conforming to the 
requirements of the Board's regulations (15 CFR 400.22) was received on 
March 8, 2024.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz.
    The proposed finished products for research and development 
include: drug products containing the following active pharmaceutical 
ingredients: MK-7962 Sotatercept, MK-3475A monoclonal antibody, MK-2060 
monoclonal antibody, MK-6024 Efinopegdutide, and, MK-5475 hypertension; 
clinical placebos; and, blinded clinical trial kits (duty rate ranges 
from duty-free to 6.5%, and 40 cents/kg+10.4%).
    The proposed foreign-status materials and components include: 
active pharmaceutical ingredients: MK-5475 Hypertension, MK-6024 
Efinopegdutide, MK-7962 Sotatercept, MK-3475A monoclonal antibody, and 
MK-2060 monoclonal antibody; syringes and syringe parts: barrels, hubs, 
plungers, needles; autoinjectors and autoinjector subassemblies: 
casings and dosing mechanisms; and, empty gelatin capsules (duty rate 
ranges from duty-free to 6.5%). The request indicates that certain 
materials/components are subject to duties under section 301 of the 
Trade Act of 1974 (section 301), depending on the country of origin. 
The applicable section 301 decisions require subject merchandise to be 
admitted to FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt April 29, 2024.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Diane Finver at 
[email protected].

    Dated: March 12, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-05676 Filed 3-15-24; 8:45 am]
BILLING CODE 3510-DS-P